Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.5B
46M shares
52-week range
$29.06 – $55.00
14% from low
Sector
ELECTRONIC COMPUTERS
Exchange
NASDAQ
CS
P/S (TTM)
1.2
EV / FCF (TTM)
10.0
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
www.omnicell.comNo one on the platform currently holds OMCL.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 483,043 | $16.1M |
| Bridgewater Associatesas of 2024-12-31 | 4,959 | $220.8K |
No one on the platform has traded OMCL yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 0.2% | — | — | — | ||
| Rev. Growth % | 6.5% | 5.8% | ||||
| Profit Margin % | 0.2% | 1.4% | 2.5% | |||
| Free Cash Flow Margin % | 7.3% | 10.5% | 8.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is -3.3% on the P/E track.
At today's price, your expected annual return is +3.5% on the P/E track.
At today's price, your expected annual return is +9.4% on the P/E track.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Stocks to Watch Tomorrow, Sep 4, 2026: $BWIN — Up 57% in a Month, Testing Analyst Conviction $OMCL — Pharmacy Automation Play With a Wide Analyst Target Gap $FRPT — A “Pet Humanization” Play With 50% Implied Upside $MRAM — A Diversified Memory Play at the AI Supply Chain’s Edge Small-Cap Digital Asset Treasury Basket — A Fresh Crypto Mining Theme Still Under $2 Billion https://truthsandnews.com/markets/10-stocks-to-watch-tomorrow-sept-4-2026-small-cap-movers
View on StockTwits ↗
$ONFO follow this guy. Accurate . Stock went up 200% Friday $SXTP $WMT $OMCL
View on StockTwits ↗
https://www.marketbeat.com/earnings/reports/2026-7-30-omnicell-inc-stock/ $OMCL Omnicell Earnings Transcript
View on StockTwits ↗
$OMCL reported 0.94 EPS and 312.21 revenue for Q2. http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_content=OMCL&utm
View on StockTwits ↗
$OMCL (-11.9% pre) Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance https://ooc.bz/l/109282
View on StockTwits ↗
$OMCL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.53 up 341.67% YoY • Reported revenue of $312.21M up 7.45% YoY • Omnicell, Inc. updated its full year 2026 guidance, tightening revenue ranges to $1.225 billion - $1.245 billion while raising non-GAAP EBITDA to $175 million - $185 million and non-GAAP EPS to $2.15 - $2.30.
View on StockTwits ↗
$OMCL gets FDA warning on product use ⚠️
View on StockTwits ↗
$OMCL Current Stock Price: $43.01 Contracts to trade: $45.0 OMCL May 15 2026 Call Entry: $0.50 Exit: $0.81 ROI: 63% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Wall St is expecting 0.47 EPS for $OMCL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗
$OMCL Healthcare technology company with steady demand; growth depends on adoption and margins
View on StockTwits ↗
$OMCL $UNH $ROK $BTC.X #Mining #Earnings ‼️🔥‼️ Can we get research on the table #Investment terminology 😫😔😛
View on StockTwits ↗
$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.2B | +4.5% | $2.27 | $2.13–$2.42 | 14.4× | 5 |
| 2027 | $1.3B | +4.2% | $2.09 | $1.56–$2.59 | 15.6× | 5 |
| 2028 | $1.3B | +4.5% | $2.46 | $2.25–$2.67 | 13.3× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-30 | $0.47 | $0.94 | +101.1% |
| 2026-04-28 | $0.33 | $0.55 | +66.7% |
| 2026-02-05 | $0.47 | $0.40 | -14.9% |
| 2025-10-30 | $0.36 | $0.51 | +41.7% |
| 2025-07-31 | $0.31 | $0.45 | +45.2% |
| 2025-05-06 | $0.16 | $0.26 | +62.5% |
| 2025-02-06 | $0.57 | $0.60 | +5.3% |
| 2024-10-30 | $0.41 | $0.56 | +36.6% |
| $2.2B |
| — |
| PHRPhreesia, Inc. | $10.42 | +1.07% | $644M | — |
| SDGRSchrödinger, Inc. | $20.75 | +9.10% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry